China Sept imports soar, exports also rise

The improvement in Chinese trade data comes ahead of the Communist Party's twice-a-decade congressMore

The improvement in Chinese trade data comes ahead of the Communist Party's twice-a-decade congressMore

China's exports grew for a seventh straight month in September, on continued strength in external demand for goods from the world's second-largest economy.

"We expect the total value of exports and imports to continue to increase in the fourth quarter, and total trade hopefully will post double-digit growth for the full year", he told reporters at a briefing.

China's goods trade volume rose 16.6 percent to 20.29 trillion yuan (3.08 trillion US dollars) in the first three quarters of this year, official data showed Friday. The rise beat the poll's forecast for a 15% gain.

US's CarGurus shares surge more than 80% in IPO
The company priced its 9.4 million share public offering at $16 a share , above the expected range of $13 to $15 apiece. Shares of auto search company CarGurus popped on Thursday, the stock's first day on the public market.

Exports rose 8.1%, below forecasts of 8.8% but handily beating August's 5.5%.

In September, China's foreign trade rose 13.6 percent to 2.46 trillion yuan, with exports up 9 percent and imports up 19.5 percent.

That left the country with a trade surplus of $28.47 billion for the month, the General Administration of Customs said, the lowest since March.

Turkey accelerates Idlib military deployment
Turkey continues to increase its military presence on the western part of the Syrian border. Turkish media sources said the convoy included about 80 soldiers.

Analysts had expected China's trade surplus to have narrowed to $39.5 billion in September from August's $41.99 billion.

Capital Economics' China economist Julian Evans-Pritchard said the timing of the mid-Autumn festival this year also meant there were more working days last month than in September 2016, suggesting October figures should show a partial reversal.

Congressman may have broken law with biotech he held, watchdog says
He did not, the employee said, discuss any constituents affected or any legislation involving multiple sclerosis. Collins mentioned the drug Innate was developing - called MIS416 - without disclosing his financial interest.

Últimas notícias